The pathophysiology of hypoglycaemia in diabetes

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 15, Issue 5, 2002, Pages 330-333

  Cryer, Philip E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Defective glucose counterregulation; Hypoglycaemia unawareness; Hypoglycaemia associated autonomic failure

Indexed keywords

ADRENALIN; GLUCAGON; HYDROCORTISONE;

ARTICLE; AUTONOMIC DYSFUNCTION; DEATH; DIABETES MELLITUS; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLUCOSE TRANSPORT; HUMAN; HYPOGLYCEMIA; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; MEDIATOR; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM;

AUTONOMIC NERVOUS SYSTEM; DIABETES MELLITUS; GLUCAGON; HUMANS; HYPOGLYCEMIA; INSULIN;

EID: 0036826668     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Cryer P.E.: Hypoglycaemia: Pathophysiology, Diagnosis and Treatment. Oxford University Press, New York, 1997.
2. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329: 977-986, 1993.
3. The United Kingdom Prospective Diabetes Study Research Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352: 837-853, 1998.
4. Gerich J.E., Langlois M., Noacco C., Karam J.H., Forsham P.H.: Lack of glucagon response to hypoglycaemia in diabetes: Evidence for an intrinsic pancreatic alpha cell defect. Science 182:171-173, 1973.
5. Bolli G., De Feo P., Compagnucci P., Cartechini M.G., Angeletti G., Santeusanio F., Brunetti P., Gerich J.E.: Abnormal glucose counterregulation in insulin-dependent diabetes mellitus: interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32:134-141, 1983.
6. Dagogo-Jack S.E., Craft S., Cryer P.E.: Hypoglycaemia-associated autonomic failure in insulin dependent diabetes mellitus. J. Clin. Invest. 91: 819-828, 1993.
7. White N.H., Skor D., Cryer P.E., Bier D.M., Levandoski L., Santiago J.V.: Identification of type 1 diabetic patients at increased risk for hypoglycaemia during intensive therapy. N. Engl. J. Med. 308: 485-491, 1983.
8. Bolli G.B., De Feo P., De Cosmo, S., Perriello G., Ventura M.M., Massi-Benedetti M., Santeusanio F., Gerich J.E., Brunetti P.: A reliable and reproducible test for adequate glucose counterregulation in type 1 diabetes. Diabetes 33: 732-737, 1984.
9. Gold A.E., MacLeod K.M., Frier B.M.: Frequency of severe hypoglycaemia in patients with type 1 diabetes with impaired awareness of hypoglycaemia. Diabetes Care 17: 697-703, 1994.
10. Fanelli C.G., Paramore D.S., Hershey T., Terkamp C., Ovalle F., Craft S., Cryer P.E.: Impact of nocturnal hypoglycaemia on hypoglycaemic cognitive dysfunction in type 1 diabetes mellitus. Diabetes 47: 1920-1927, 1998.
11. Ovalle F., Fanelli C.G., Paramore D.S., Hershey T., Craft S., Cryer P.E.: Brief twice weekly episodes of hypoglycaemia reduce detection of clinical hypoglycaemia in type 1 diabetes mellitus. Diabetes 47: 1472-1479, 1998.
12. Fanelli C.G., Pampanelli S., Epifano L., Rambotti A.M., Vincenzo A.D., Modarelli F., Ciofetta M., Lepore M., Annibale B., Torlone E., Perriello G., De Feo P., Santeusanio F., Brunetti P., Bolli G.B.: Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia following institution of rational intensive therapy in IDDM. Diabetologia 37: 1265-1276, 1994.
13. Cranston I., Lomas J., Maran A., Macdonald L, Amiel S.: Restoration of hypoglycaemia unawareness in patients with long duration insulin-dependent diabetes mellitus. Lancet 344: 283-287, 1994.
14. Dagogo-Jack S., Rattarasarn C., Cryer P.E.: Reversal of hypoglycaemia unawareness, but not defective glucose counterregulation in IDDM. Diabetes 43: 1426-1434, 1994.
15. Davis S.N., Shavers C., Costa F., Mosqueda-Garcia R.: Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycaemia in normal humans. J. Clin. Invest. 98: 680-691, 1996.
16. Galassetti P., Mann S., Tate D., Neill R.A., Costa F., Wassermann D.H., Davis S.N.: Effects of antecedent prolonged exercise on subsequent counterregulatory responses to hypoglycaemia. Am. J. Physiol. 280: E908-E917, 2001.
17. McGregor V.P., Greiwe J.S., Banarer S., Cryer P.E.: Limited impact of vigorous exercise on defenses against hypoglycaemia. Diabetes 51: 1485-1492, 2002.
18. Simpson I.A., Appel N.M., Hokari M., Oki J., Holman G.D., Maher F., Koehler-Stec E.M., Vannucci S.J., Smith Q.R.: Blood-barrier glucose transporter: Effects of hypo- and hyperglycemia revisited. J. Neurochem. 72: 238-247, 1999.
19. Boyle P.J., Nagy R.J., O'Connor A.M., Kempers S.F., Yeo R.A., Qualls C.: Adaptation in brain glucose uptake following recurrent hypoglycaemia. Proc. Natl. Acad. Sci. USA 91: 9352-9356, 1994.
20. Boyle P.J., Kempers S.F., O'Connor A.M., Nagy R.J.: Brain glucose uptake and unawareness of hypoglycaemia in patients with insulin dependent diabetes mellitus. N. Engl. J. Med. 333: 1726-1731, 1995.
21. Segel S.A., Fanelli C.G., Dence C.S., Markham J., Videen T.O., Paramore D.S., Powers W. J., Cryer P.E.: Blood-to-brain glucose transport, cerebral glucose metabolism and cerebral blood flow are not increased following hypoglycaemia. Diabetes 50: 1911-1917, 2001.
22. The United Kingdom Prospective Diabetes Study Research Group: Overview of 6 years of therapy of type II diabetes: a progressive disease. Diabetes 44: 1249-1258, 1995.
23. The United Kingdom Prospective Diabetes Study Research Group: A 6-year, randomized, controlled trial comparing sulfonylurea, insulin and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann. Intern. Med. 128: 165-175, 1998.
24. Hepburn D.A., MacLeod K.M., Pell A.C.H., Scougal I.J., Frier B.M.: Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet. Med. 10: 231-237, 1993.
25. Segel S., Paramore D., Cryer P.: Hypoglycaemia-associated autonomic failure in advanced type 2 diabetes mellitus. Diabetes 51: 729-733, 2002.
26. Fukuda M., Tanaka A., Tahara Y., Ikegami H., Yamamoto Y., Kumahara Y., Shima K:. Correlation between minimal secretory capacity of pancreatic β-cells and stability of diabetic control. Diabetes 37: 81-88, 1988.
27. Samols E., Stagner J.I., Ewart R.B.L., Marks V.: The order of islet microvascular cellular perfusion is BÆAÆD in the perfused rat pancreas. J. Clin. Invest. 82: 350-353, 1988.
28. Maruyama H., Hisatoni A., Orci L., Grodsky G.M., Unger R.H.: Insulin within islets is a physiologic glucagon release inhibitor. J. Clin. Invest. 74: 2296-2299, 1984.
29. Banarer S., McGregor V.P., Cryer P.E.: Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 51: 958-965, 2002.